RhumbLine Advisers’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-59,653
Closed -$21.4K 4317
2024
Q2
$21.4K Sell
59,653
-159,173
-73% -$57K ﹤0.01% 3862
2024
Q1
$147K Buy
218,826
+3,619
+2% +$2.43K ﹤0.01% 3311
2023
Q4
$117K Sell
215,207
-90
-0% -$49 ﹤0.01% 3402
2023
Q3
$129K Buy
215,297
+3,159
+1% +$1.9K ﹤0.01% 3372
2023
Q2
$276K Buy
212,138
+2,369
+1% +$3.08K ﹤0.01% 3067
2023
Q1
$369K Buy
209,769
+15,673
+8% +$27.6K ﹤0.01% 2545
2022
Q4
$609K Buy
194,096
+5,762
+3% +$18.1K ﹤0.01% 2371
2022
Q3
$923K Buy
188,334
+16,601
+10% +$81.4K ﹤0.01% 2171
2022
Q2
$711K Buy
171,733
+40,028
+30% +$166K ﹤0.01% 2316
2022
Q1
$765K Sell
131,705
-8,249
-6% -$47.9K ﹤0.01% 2242
2021
Q4
$1.05M Sell
139,954
-2,146
-2% -$16.1K ﹤0.01% 2183
2021
Q3
$1.28M Buy
142,100
+4,285
+3% +$38.6K ﹤0.01% 2120
2021
Q2
$1.65M Sell
137,815
-6,695
-5% -$80.2K ﹤0.01% 2032
2021
Q1
$1.81M Sell
144,510
-12,117
-8% -$152K ﹤0.01% 1965
2020
Q4
$2.44M Buy
156,627
+5,381
+4% +$84K ﹤0.01% 1751
2020
Q3
$1.43M Sell
151,246
-42,504
-22% -$402K ﹤0.01% 1852
2020
Q2
$1.74M Buy
193,750
+24,186
+14% +$217K ﹤0.01% 1810
2020
Q1
$1.08M Buy
169,564
+5,970
+4% +$38K ﹤0.01% 1843
2019
Q4
$1.37M Buy
163,594
+7,174
+5% +$60K ﹤0.01% 1950
2019
Q3
$1.42M Buy
156,420
+5,683
+4% +$51.4K ﹤0.01% 1888
2019
Q2
$1.62M Buy
150,737
+18,138
+14% +$195K ﹤0.01% 1856
2019
Q1
$1.27M Sell
132,599
-2,024
-2% -$19.3K ﹤0.01% 1924
2018
Q4
$1.55M Buy
134,623
+43,418
+48% +$498K ﹤0.01% 1803
2018
Q3
$1.55M Sell
91,205
-6,555
-7% -$111K ﹤0.01% 1797
2018
Q2
$1.39M Buy
97,760
+18,815
+24% +$267K ﹤0.01% 1866
2018
Q1
$1.5M Sell
78,945
-87
-0.1% -$1.65K ﹤0.01% 1756
2017
Q4
$1.3M Sell
79,032
-9,784
-11% -$160K ﹤0.01% 1836
2017
Q3
$1.33M Buy
88,816
+6,125
+7% +$91.9K ﹤0.01% 1838
2017
Q2
$728K Sell
82,691
-2,391
-3% -$21.1K ﹤0.01% 2121
2017
Q1
$442K Buy
85,082
+2,549
+3% +$13.2K ﹤0.01% 2303
2016
Q4
$252K Buy
82,533
+5,330
+7% +$16.3K ﹤0.01% 2572
2016
Q3
$357K Sell
77,203
-570
-0.7% -$2.64K ﹤0.01% 2389
2016
Q2
$450K Buy
77,773
+5,370
+7% +$31.1K ﹤0.01% 2255
2016
Q1
$438K Buy
72,403
+420
+0.6% +$2.54K ﹤0.01% 2308
2015
Q4
$657K Buy
71,983
+7,975
+12% +$72.8K ﹤0.01% 2076
2015
Q3
$361K Sell
64,008
-3,462
-5% -$19.5K ﹤0.01% 2434
2015
Q2
$748K Sell
67,470
-4,995
-7% -$55.4K ﹤0.01% 2066
2015
Q1
$1.14M Buy
72,465
+10,435
+17% +$164K ﹤0.01% 1775
2014
Q4
$943K Buy
62,030
+955
+2% +$14.5K ﹤0.01% 1854
2014
Q3
$659K Sell
61,075
-3,875
-6% -$41.8K ﹤0.01% 2046
2014
Q2
$992K Buy
64,950
+6,066
+10% +$92.6K ﹤0.01% 1826
2014
Q1
$1.07M Buy
58,884
+1,710
+3% +$30.9K ﹤0.01% 1761
2013
Q4
$794K Buy
57,174
+6,900
+14% +$95.8K ﹤0.01% 1967
2013
Q3
$527K Sell
50,274
-501
-1% -$5.25K ﹤0.01% 2173
2013
Q2
$397K Buy
+50,775
New +$397K ﹤0.01% 2433